ResMed

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$1,422,808
$1,335,582
$1,347,993
$1,291,736
Gross Profit
884,660
820,820
820,070
766,408
EBITDA
566,426
503,284
532,341
469,603
EBIT
504,096
455,586
458,053
417,693
Net Income
392,593
348,536
379,705
365,041
Net Change In Cash
1,422,808
1,335,582
1,347,993
1,291,736
Free Cash Flow
311,206
414,356
508,181
554,873
Cash
1,417,069
1,383,848
1,209,450
932,711
Basic Shares
147,037
147,037
147,037
147,220

Annual Financials

Values in thousands2025-06-302024-06-302023-06-302022-06-30
Revenue
$5,146,327
$4,685,297
$4,222,993
$3,578,127
Gross Profit
3,054,970
2,655,303
2,355,662
2,024,311
EBITDA
1,913,377
1,533,543
1,358,801
1,176,636
EBIT
1,677,566
1,317,334
1,162,279
982,795
Net Income
1,400,723
1,020,951
897,556
779,437
Net Change In Cash
5,146,327
4,685,297
4,222,993
3,578,127
Free Cash Flow
1,661,723
1,286,404
559,299
195,111
Cash
1,209,450
238,361
227,891
273,710
Basic Shares
147,340
147,550
147,455
147,043

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$2.81
2025-09-30
$2.55
2025-06-30
$2.55